Literature DB >> 10092092

Requirement of PEST domain tyrosine phosphatase PEP in B cell antigen receptor-induced growth arrest and apoptosis.

K Hasegawa1, H Yajima, T Katagiri, M Ogimoto, Y Arimura, K Mitomo, K Mashima, K Mizuno, H Yakura.   

Abstract

Signaling events leading to B cell growth or apoptosis are beginning to be unravelled, but detailed information is still lacking. To identify signaling molecules involved in B cell antigen receptor (BCR)-initiated pathways, we used the immature B cell line, WEHI-231, to investigate protein tyrosine phosphatases (PTP) whose expression was modulated by BCR ligation. Among the PTP cloned by reverse transcription-PCR, mRNA expression of the proline-, glutamic acid-, serine- and threonine-rich (PEST) domain phosphatase (PEP) was selectively elevated 3.1-fold within 3 h after anti-IgM antibody stimulation. In contrast, expression of another PEST domain phosphatase, PTP-PEST, was unaffected. Western blot analysis revealed that 71% of PEP was located in the cytosolic fraction, while 29% was in the membrane fraction. To examine the direct contribution made by PEP to BCR-initiated signal transduction, we transfected an antisense PEP cDNA into WEHI-231 cells. Two stable clones were established in which PEP expression was reduced by 34% and 47%, respectively. Strikingly, BCR-mediated inhibition of DNA synthesis was significantly rescued in the clones, and G1 phase cell cycle arrest and apoptosis were almost completely ablated. Considered collectively, these results indicate that PEP is a positive, crucial regulator in determining B cell fate triggered by BCR engagement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092092     DOI: 10.1002/(SICI)1521-4141(199903)29:03<887::AID-IMMU887>3.0.CO;2-9

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

2.  Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.

Authors:  Adrian F Arechiga; Tania Habib; Yantao He; Xian Zhang; Zhong-Yin Zhang; Andrew Funk; Jane H Buckner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

3.  A systems toxicology approach identifies Lyn as a key signaling phosphoprotein modulated by mercury in a B lymphocyte cell model.

Authors:  Joseph A Caruso; Paul M Stemmer; Alan Dombkowski; Nicholas J Caruthers; Randall Gill; Allen J Rosenspire
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-14       Impact factor: 4.219

4.  Leupaxin binds to PEST domain tyrosine phosphatase PEP.

Authors:  Noriyuki Watanabe; Natsuko Amano; Hajime Ishizuka; Keisuke Mashima
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

5.  Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion.

Authors:  T Ort; S Voronov; J Guo; K Zawalich; S C Froehner; W Zawalich; M Solimena
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 6.  The role of PTPN22 risk variant in the development of autoimmunity: finding common ground between mouse and human.

Authors:  David J Rawlings; Xuezhi Dai; Jane H Buckner
Journal:  J Immunol       Date:  2015-04-01       Impact factor: 5.422

7.  Caspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response.

Authors:  Maxime Hallé; Ying-Chih Liu; Serge Hardy; Jean-François Théberge; Christophe Blanchetot; Annie Bourdeau; Tzu-Ching Meng; Michel L Tremblay
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

8.  Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic Mice.

Authors:  Heather I Fraser; Sarah Howlett; Jan Clark; Daniel B Rainbow; Stephanie M Stanford; Dennis J Wu; Yi-Wen Hsieh; Christian J Maine; Mikkel Christensen; Vijay Kuchroo; Linda A Sherman; Patricia L Podolin; John A Todd; Charles A Steward; Laurence B Peterson; Nunzio Bottini; Linda S Wicker
Journal:  J Immunol       Date:  2015-10-05       Impact factor: 5.422

9.  Tracking Differential Gene Expression in MRL/MpJ Versus C57BL/6 Anergic B Cells: Molecular Markers of Autoimmunity.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Biomark Insights       Date:  2008-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.